Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Apr 27, 2016
Biocon Ltd (BSE code: 532523, NSE: BIOCON), Asia's premier biopharmaceuticals company, announced its Q4 & FY16 results. Kiran Mazumdar Shaw, Chairperson and Managing Director talks on Highlights and performance of Biocon.